Government Pharmaceutical Organization Accelerates Production of Oseltamivir Treatment for the Flu, Adds Favipiravir to National Essential Medicines List
Government Pharmaceutical Organization Accelerates Production of Oseltamivir Treatment for the Flu, Adds Favipiravir to National Essential Medicines List
The Government Pharmaceutical Organization is taking swift action to address the rapid spread of influenza and the subsequent rise in patients. Dr. Mingkwan Suphanphong, Director of the Government Pharmaceutical Institute, emphasized the urgent need for medications and announced that the institute has expedited the production of Oseltamivir, a treatment for influenza. To meet the increased demand, an additional 26 million tablets of Oseltamivir have been reserved and production has been intensified.
To ensure sufficient supply, Oseltamivir will be produced in three different sizes: 30 milligrams for small children, 45 milligrams for older children, and 75 milligrams for adults. Currently, the Government Pharmaceutical Organization has 2,800 kilograms of raw materials, which can be used to manufacture approximately 26 million tablets of Oseltamivir. The tablets for infants will be available for delivery on October 4th, while the 45-milligram tablets will be distributed no later than October 9th. The 75-milligram tablets for adults will be made available by October 2023 at the latest.
In addition to Oseltamivir, the organization has also gathered a reserve of 1.6 million Favipiravir tablets, with the capacity to produce an additional 880,000 tablets. Recognizing the effectiveness of Favipiravir in treating influenza virus infection, the Government Pharmaceutical Organization has written a letter to the FDA, urging them to include this medication in the national list of essential medicines.
Dr. Mingkwan Suphanphong reassured the public that the organization is fully committed to maintaining an adequate and thorough supply of medicines and raw materials. In case of urgent need, the institute has the capability to expedite production immediately.
The Government Pharmaceutical Organization’s proactive measures aim to provide effective treatments and ensure the well-being of the population during the flu outbreak.
Government Pharmaceutical Organization Accelerating the production of oseltamivir treatment ‘Influenza’ reserves 26 million additional tablets to support the outbreak of influenza and has written a letter to the FDA to bring ‘favipiravir’ into the national list of essential medicines to use in the flu. Ready to send to the hospital immediately, 1.6 million tablets
Government Pharmaceutical Organization Accelerating the production of oseltamivir treatment ‘Influenza’ reserves 26 million additional tablets to support the outbreak of influenza and has written a letter to the FDA to bring ‘favipiravir’ into the national list of essential medicines to use in the flu. Ready to send to the hospital immediately, 1.6 million tablets
Dr. Mingkwan Suphanphong, DirectorGovernment Pharmaceutical Institute He revealed that from the situationFluwhich continues to spread wide expansion Until it leads to an increase in the number of patients So the Government Pharmaceutical Institute has accelerated the process of supplying medicines. Oseltamivir for hospitals that have ordered all the medicine since mid-September But since the demand for the drug has increased 4-5 times, production has been accelerated. Backup medicationit must be produced in all 3 sizes, for children and adults For small children, 30 milligrams, for older children, 45 milligrams, for adults, 75 milligrams.
Currently, about 2,800 kilograms of raw materials are available, which can be made into about 26 million oseltamivir tablets. All oseltamivir 30 mg tablets for babies will be ready for delivery on October 4. The quantity will 45-milligram will be distributed no later than October 9, and the 75-milligram size for adults will be phased in by October 2023 at the latest.
Related news
In addition, the Director of the Government Pharmaceutical Institute He went on to say: The organization also has a reserve of 1.6 million favipiravir tablets and has raw materials that can produce another 880,000 tablets. Prepared a letter to the FDA for the subcommittee. National list of essential medicines consider asking to bring medicinesFavipiravirIt has also been added to the national list of essential medicines for indications for influenza virus infection.
in
“Let the people be sure that the organization can prepare medicines that are effective in the treatment and preservation of raw materials to maintain them adequately and thoroughly. If there is an urgent need for use, additional production can be expedited immediately,” said the Director of the Government Pharmaceutical Institute.
Related content
#Government #Pharmaceutical #Organization #keeping #million #flu #tablets #outbreak
